Marco Metra
A5053760015- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Cardiac pacing and defibrillation studies
- Cardiac Valve Diseases and Treatments
- Cardiac Structural Anomalies and Repair
- Potassium and Related Disorders
- Cardiac electrophysiology and arrhythmias
- Mechanical Circulatory Support Devices
- Cardiovascular and exercise physiology
- Cardiac Imaging and Diagnostics
- Atrial Fibrillation Management and Outcomes
- Diabetes Treatment and Management
- Cardiac Arrhythmias and Treatments
- Cardiovascular Issues in Pregnancy
- Cardiac Arrest and Resuscitation
- Blood Pressure and Hypertension Studies
- COVID-19 Clinical Research Studies
- Infective Endocarditis Diagnosis and Management
- Health Systems, Economic Evaluations, Quality of Life
- Electrolyte and hormonal disorders
- Cardiovascular Effects of Exercise
- Pulmonary Hypertension Research and Treatments
- Heart Rate Variability and Autonomic Control
- Pregnancy-related medical research
- Cardiomyopathy and Myosin Studies
University of Brescia
2016-2025
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
2016-2025
Surgical Specialties (Canada)
2015-2024
Brescia University
2007-2024
St. Anne's University Hospital Brno
2024
Sequoia (United States)
2024
SEQUOIA (Italy)
2024
Surgical Specialties (United States)
2016-2024
Ospedale Policlinico San Martino
2024
University of Genoa
2024
of the individual patients, in consultation with that patient, and where appropriate necessary patient's guardian or carer.It is also health professional's responsibility to verify rules regulations applicable drugs devices at time prescription.
Virus infection has been widely described as one of the most common causes myocarditis. However, less is known about cardiac involvement a complication severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.To describe presentation myocardial inflammation in patient with disease 2019 (COVID-19) who recovered from influenzalike and developed fatigue signs symptoms heart failure week after upper tract symptoms.This case report describes an otherwise healthy 53-year-old woman...
Guidelines and Expert Consensus documents aim to present management recommendations based on all of the relevant evidence a particular subject in order help physicians select best possible strategies for individual patient, suffering from specific condition, taking into account not only impact outcome, but also risk benefit ratio diagnostic or therapeutic procedure. The ESC guidelines production can be found website†. In brief, appoints experts field carry out comprehensive critical...
65-74 years, Sex category (female) CIED Cardiac implantable electronic device CML Chronic myeloid leukaemia CMR magnetic resonance COMPASS-CAT Prospective COmparison of Methods for thromboembolic
Sodium-glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of hospitalization for heart failure or death from cardiovascular causes among patients with stable failure. However, safety and efficacy SGLT2 when initiated soon after an episode decompensated are unknown.We performed a multicenter, double-blind trial in which type diabetes mellitus who were recently hospitalized worsening randomly assigned to receive sotagliflozin placebo. The primary end point was total number deaths...
Nesiritide is approved in the United States for early relief of dyspnea patients with acute heart failure. Previous meta-analyses have raised questions regarding renal toxicity and mortality associated this agent.We randomly assigned 7141 who were hospitalized failure to receive either nesiritide or placebo 24 168 hours addition standard care. Coprimary end points change at 6 hours, as measured on a 7-point Likert scale, composite point rehospitalization death within 30 days.Patients...
à Use of Class III is discouraged by the ESC. Levels EvidenceLevel Evidence A Data derived from multiple randomized clinical trials or meta-analyses Level B a single trial large nonrandomized studies C Consensus opinion experts and/or small studies; retrospective and registriesFigure 1 Clinical classification mode heart failure (Forrester classification).H I-IV refers to haemodynamic severity, with reference figures for CI pulmonary capillary pressures shown on vertical horizontal axes,...
Poland), and Katja Zeppenfeld (
Abstract Aims To evaluate the impact of COVID-19 pandemic on patient admissions to Italian cardiac care units (CCUs). Methods and Results We conducted a multicentre, observational, nationwide survey collect data for acute myocardial infarction (AMI) at CCUs throughout 1 week period during outbreak, compared with equivalent in 2019. observed 48.4% reduction AMI 2019 (P < 0.001). The was significant both ST-segment elevation [STEMI; 26.5%, 95% confidence interval (CI) 21.7–32.3; P =...
It is important that the medical profession plays a significant role in critically evaluating use of diagnostic procedures and therapies as they are introduced tested detection, management, or prevention disease states. Rigorous expert analysis available data documenting absolute relative benefits risks those can produce helpful guidelines improve effectiveness care, optimize patient outcomes, favorably affect overall cost care by focusing resources on most effective strategies. The...
8.1.6.1.7. Sotalol . 8.1.6.2. Drugs with unproven efficacy or no longer recommended .8.1.6.2.1.Digoxin .8.1.6.2.2.Procainamide .8.1.6.2.3.Quinidine .8.1.6.2.4.Verapamil and diltiazem .8.1.7.Out-of-hospital initiation of antiarrhythmic drugs in patients atrial fibrillation
Corrigendum to: ‘ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation–executive summary. A report American College Cardiology/American Heart Association Task Force on practice and European …